April 7, 2026
NovaBridge Biosciences
2440 Research Boulevard, Suite 400 Rockville, MD 20850 United States
Dear Sir/Madam:
We hereby consent to the reference of our name under the headings “Item 10. Additional Information—E. Taxation—PRC Taxation” in NovaBridge’s Annual Report on Form 20-F for the year ended December 31, 2025 (the “Annual Report”), which will be filed with the Securities and Exchange Commission(the “SEC”) on the date hereof. We also consent to the filing of this consent letter with the SEC as an exhibit to the Annual Report.
In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, or under the Securities Exchange Act of 1934, in each case, as amended, or the regulations promulgated thereunder.
Very truly yours,
JunHe LLP